Earlier this year, Cancer Research UK announced their renewed support for the Convergence Science Centre at the Institute of Cancer Research and Imperial College London for the next quinquennium. To celebrate this achievement, our Scientific Director, Professor Axel Behrens, presented our new scientific strategy and goals for the next five years.

His address covered our vision for the future of cancer research, introduced the exciting research opportunities Convergence offers, and established how we can work together to tackle cancer’s toughest challenges and bring pioneering treatments to patients faster. The Centre will build on the wealth of expertise and infrastructure across the partner institutions that will allow us to deliver ambitious, cross-disciplinary translational convergence cancer research at the scale required to address unmet medical needs in all cancers, and bottlenecks impeding innovations in our clinical practice. To achieve this, we know the importance of investing in new approaches, training and ‘blue sky thinking’; we explained how the Centre can support scientists in their development and research.

Here is the recording of the presentation: